On December 6, 2025, Jiudian Pharmaceutical held the “Change Your Pain Patch, Change to Jiudian” brand upgrade press conference, inviting over 300 key executives from mainstream pharmacy chains and commercial companies across China to witness the company’s comprehensive revitalization in the external pain relief field. The company officially began its strategic transformation from a “product-centric” focus to a “dual-core” drive of both “products and brand,” with a clearer image and positioning to expand the vast potential of the outpatient market.

Currently, China’s external pain relief market is developing in a unique direction. With the aging population and a growing number of young people suffering from occupational and sports injuries, the chronic pain demographic continues to increase. In recent years, the demand for external pain relief products has steadily risen. However, this market has long faced challenges such as product homogeneity, a limited variety of chemical drugs, and a lack of dominant brands leading the way. In response, Jiudian Pharmaceutical is taking the lead in brand revitalization, aiming to reshape the competitive landscape of the external pain relief market.

During the press conference, Jiudian Pharmaceutical partnered with top-tier domestic brand marketing consulting agencies to introduce the "Jiudian Pain Relief Specialist" as its super symbol, reinforcing its brand positioning as a “pain relief patch expert.” The new brand slogan, “Change Your Pain Patch, Change to Jiudian,” directly addresses consumer pain points, conveying a professional and trustworthy brand image. The company also unveiled the new packaging for its entire product line, featuring a unified visual identity to elevate brand recognition. Additionally, the 2026 brand promotion plan was revealed, which includes five growth engines—action, display, brand, online, and events—to support the brand upgrade, ignite the category, and break through market barriers.

One of the highlights of the conference was the launch of Jiudian Pharmaceutical’s new pain relief patch product—Warm Moxa-Substitute Plaster, which introduces the new concept of "warming moxibustion in a patch." This exclusive Medicare-covered product strengthens Jiudian’s position in the pain relief patch market. Mr. Yang, General Manager of Jiudian Pharmaceutical, stated at the conference that, with the full-category product layout of “Traditional Chinese Medicine + Chemical Medicine” and “External Use + Oral Medicine,” Jiudian has built a comprehensive product matrix covering all pain scenarios and has further solidified its competitive edge in the pain relief patch market.

Mr. Cheng, Vice President of Minet, delivered a keynote speech on "Pain Category: A Bright Future," highlighting that pain relief will be one of the growth highlights in the OTC field. With 25 years of experience, Jiudian Pharmaceutical has accumulated deep expertise in R&D, production capacity, and channels, creating a clear competitive advantage in the pain relief category. Mr. Cheng stated, “Building on this foundation, Jiudian’s early brand upgrade actions will help the company gain a mental edge and become a benchmark in this niche market.”

Following the brand upgrade launch, Jiudian will gradually implement precise and efficient market strategies under its new brand system. In the future, Jiudian is expected to lead the external pain relief market towards brandization and standardization, contributing new strength to the industry’s high-quality development as the "Pain Relief Patch Expert."